# TSHA ETFs: 43 Funds That Hold Taysha Gene Therapies > 43 thematic and core ETFs hold Taysha Gene Therapies (TSHA). IBRN holds the most, at 1.65% of the fund on Nov 3, 2026. Weights and dates for every holder. Data as of Nov 5, 2026. Rebuilt every trading night. ## ETFs that hold Taysha Gene Therapies 43 thematic and core ETFs hold Taysha Gene Therapies , by holdings dated Jun 30, 2026 to Nov 3, 2026 . IBRN holds the most, at 1.65% of the fund on Nov 3, 2026 . The next largest are SBIO (0.84%) and BBC (0.69%). 1 income and other fund on it is listed below. ### Thematic and core funds that hold it | Fund | Name | Share of the fund | Holdings filed | Asset | | --- | --- | --- | --- | --- | | IBRN | iShares Neuroscience and Healthcare ETF | 1.65% | Nov 3, 2026 | Equity | | SBIO | ALPS Medical Breakthroughs ETF | 0.84% | Aug 31, 2026 | Equity | | BBC | Virtus Biotech Clinical Trials ETF | 0.69% | Jul 31, 2026 | Equity | | SGRW | Harbor Active Small Cap Growth ETF | 0.67% | Jul 31, 2026 | Equity | | XBI | State Street SPDR S&P Biotech ETF | 0.21% | Nov 3, 2026 | Equity | | SEIS | SEI Select Small Cap ETF | 0.19% | Jun 30, 2026 | Equity | | ESSC | Eventide Small Cap ETF | 0.15% | Jul 31, 2026 | Equity | | FSEG | Fidelity Enhanced Small Cap Growth ETF | 0.15% | Jun 30, 2026 | Equity | | FESM | Fidelity Enhanced Small Cap Core ETF | 0.10% | Jun 30, 2026 | Equity | | IBBQ | Invesco Nasdaq Biotechnology ETF | 0.09% | Nov 3, 2026 | Equity | | VTWG | Vanguard Russell 2000 Growth ETF | 0.09% | Sep 30, 2026 | Equity | | VFMO | Vanguard U.S. Momentum Factor ETF | 0.08% | Sep 30, 2026 | Equity | | RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.08% | Jul 31, 2026 | Equity | | KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.07% | Jul 31, 2026 | Equity | | IBB | iShares Biotechnology ETF | 0.07% | Nov 3, 2026 | Equity | | IWO | iShares Russell 2000 Growth ETF | 0.07% | Nov 3, 2026 | Equity | | KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.07% | Nov 3, 2026 | Equity | | TXS | Texas Capital Texas Equity Index ETF | 0.06% | Jun 30, 2026 | Equity | | GINN | Goldman Sachs Innovate Equity ETF | 0.06% | Aug 31, 2026 | Equity | | PWS | Pacer WealthShield ETF | 0.06% | Jul 31, 2026 | Equity | | RESM | Columbia Research Enhanced Small Cap ETF | 0.05% | Jun 30, 2026 | Equity | | RSSL | Global X Russell 2000 ETF | 0.04% | Jul 31, 2026 | Equity | | VTWO | Vanguard Russell 2000 ETF | 0.04% | Sep 30, 2026 | Equity | | IWM | iShares Russell 2000 ETF | 0.04% | Nov 3, 2026 | Equity | | SCHA | Schwab U.S. Small-Cap ETF | 0.03% | Aug 31, 2026 | Equity | | ISCG | iShares Morningstar Small-Cap Growth ETF | 0.03% | Nov 3, 2026 | Equity | | GSSC | GS ActiveBeta U.S. Small Cap Equity ETF | 0.03% | Aug 31, 2026 | Equity | | TEXN | iShares Texas Equity ETF | 0.02% | Nov 3, 2026 | Equity | | ISCB | | 0.02% | Jul 31, 2026 | Equity | | PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.02% | Nov 3, 2026 | Equity | | FHLC | Fidelity MSCI Health Care Index ETF | 0.02% | Jul 31, 2026 | Equity | | VXF | Vanguard Extended Market ETF | 0.02% | Sep 30, 2026 | Equity | | VHT | Vanguard Health Care ETF | 0.01% | Sep 30, 2026 | Equity | | MSML | iShares MSCI USA Small-Cap ETF | 0.01% | Nov 3, 2026 | Equity | | WSML | iShares MSCI World Small-Cap ETF | 0.01% | Nov 3, 2026 | Equity | | MSSM | Morgan Stanley Pathway Small-Mid Cap Equity ETF | 0.01% | Aug 31, 2026 | Equity | | ONEQ | Fidelity Nasdaq Composite Index ETF | 0.01% | Aug 31, 2026 | Equity | | TILT | Northern Trust Morningstar US Market Factor Tilt ETF | Taysha Gene Therapies (ticker TSHA, listed in US) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date. Shares, preferred shares and debt are told by each fund’s N-PORT asset type. A fund holding only the company’s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out. Each row shows the date the fund last filed. Look up another company . ### Questions people ask Which ETFs hold Taysha Gene Therapies? 43 thematic and core ETFs hold Taysha Gene Therapies, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are IBRN at 1.65% of the fund on Nov 3, 2026, SBIO at 0.84% of the fund on Aug 31, 2026 and BBC at 0.69% of the fund on Jul 31, 2026. 1 income and other fund on it is listed apart. --- Source: ETFIQ, independent ETF data. Recomputed nightly from public filings and prices. Cite: ETFIQ, ETFs holding TAYSHA GENE THERAPIES, data as of Nov 5, 2026. https://etfiq.com/holdings/tsha/ Licence: https://etfiq.com/license/ Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms. HTML: https://etfiq.com/holdings/tsha/